Now Dotmatics, a leader in research and development scientific software, wants to give drug researchers the power of AI to speed up their development of new, life-saving and improving drugs.
Today, the Boston-based company launches Geneious Luma, a powerful new bioinformatics solution for antibody discovery, built on its Luma Scientific Intelligence Platform.